Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine-Reference-Cited by-同舟云学术

Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine

Published:2004-10 Issue:1 Volume:66 Page:49-56
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Garg Satish K.,Gottlieb Peter A.,Hisatomi Mary E.,D’Souza Anna,Walker Andrew J.,Izuora Kenneth E.,Chase H.Peter

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference22 articles.

1. Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependant diabetes mellitus. N. Engl. J. Med. 329 (1993) 977–986.

2. UK Prospective Diabetes Study (UKPDS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352 (1998) 837–853.

3. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective six year study;Ohkubo;Diab. Res. Clin. Pract,1995

4. Pre-meal insulin analogue insulin Lispro vs. Human R insulin treatment in young subjects with type 1 diabetes;Garg;Diab. Med,1996

5. Effect of the fast-acting insulin lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. UK Lispro Study Group;Heller;Diab. Care,1999

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes;Pediatric Diabetes;2022-12

2. Evaluation of Insulin and Glucagon-Like Peptide-1 Analog Sales in Turkey Before the Pandemic Period; Projection for Upcoming Years: A Market Analysis Study;Sakarya Medical Journal;2022-10-07

3. Insulin Past, Present, and Future: 100 Years from Leonard Thompson;Diabetology;2022-02-09

4. Factors Associated with Medicine Timing Effects: A Meta-analysis;2021-10-26

5. Circadian Variation in Efficacy of Medications;Clinical Pharmacology & Therapeutics;2020-11-29